Exact Mass: 401.2016

Exact Mass Matches: 401.2016

Found 49 metabolites which its exact mass value is equals to given mass value 401.2016, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Evogliptin

Evogliptin

C19H26F3N3O3 (401.1926)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Evogliptin

4-[3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one

C19H26F3N3O3 (401.1926)


   

1,4-Bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)azetidin-2-one

C26H27NO3 (401.1991)


   

Risdiplam

7-{4,7-diazaspiro[2.5]octan-7-yl}-2-{2,8-dimethylimidazo[1,2-b]pyridazin-6-yl}-4H-pyrido[1,2-a]pyrimidin-4-one

C22H23N7O (401.1964)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System M - Musculo-skeletal system

   

31F508a2

Bioxalomycin alpha2

C21H27N3O5 (401.1951)


   

3-(1-(cyclohexylmethyl)-1h-indazole-3-carboxamido)-2,2-dimethylsuccinic acid

3-(1-(cyclohexylmethyl)-1h-indazole-3-carboxamido)-2,2-dimethylsuccinic acid

C21H27N3O5 (401.1951)


   
   
   

Hexanoic acid, 2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide

Hexanoic acid, 2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide

C25H27N3O2 (401.2103)


   
   
   
   
   
   
   

Pyrilamine maleate

Pyrilamine Maleate Salt

C21H27N3O5 (401.1951)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Mepyramine maleate, a first generation antihistamine, is an antagonist of histamine H1 receptor, with Kds of 0.8 nM, 5200 nM and >3000 nM for H1, H2, and H3 receptor, respectively, and a pKd of 9.4 for H1 receptor.

   

dimethylazanide,tantalum(5+)

dimethylazanide,tantalum(5+)

C10H30N5Ta (401.1981)


   
   

Mafoprazine

Mafoprazine

C22H28FN3O3 (401.2115)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

1-tert-Butyl 7-methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1,7-dicarboxylate

1-tert-Butyl 7-methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1,7-dicarboxylate

C21H28BNO6 (401.201)


   

(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cyclohexylpyrrolidine-1-carboxamide

(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cyclohexylpyrrolidine-1-carboxamide

C21H28ClN5O (401.1982)


   
   

4-(HYDROXY-DIPHENYL-METHYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

4-(HYDROXY-DIPHENYL-METHYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER

C26H27NO3 (401.1991)


   

4-(6-{[(4-Methylcyclohexyl)amino]methyl}-1,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)benzoic Acid

4-(6-{[(4-Methylcyclohexyl)amino]methyl}-1,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)benzoic Acid

C25H27N3O2 (401.2103)


   

6-[Hydroxyimino-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphtalen-2-YL)-methyl]-naphtalene-2-carboxylic acid

6-[Hydroxyimino-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphtalen-2-YL)-methyl]-naphtalene-2-carboxylic acid

C26H27NO3 (401.1991)


   

Risdiplam

Risdiplam

C22H23N7O (401.1964)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System M - Musculo-skeletal system

   

11-O-demethyl-17-O-deacetylvindolinium cation

11-O-demethyl-17-O-deacetylvindolinium cation

C22H29N2O5+ (401.2076)


   

3-(4-Methoxyphenyl)-8-(6-methyl-2-phenyl-4-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol

3-(4-Methoxyphenyl)-8-(6-methyl-2-phenyl-4-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol

C25H27N3O2 (401.2103)


   
   

7-(4-Ethyl-1-piperazinyl)-2-(3-fluorophenyl)-5-phenylpyrazolo[1,5-a]pyrimidine

7-(4-Ethyl-1-piperazinyl)-2-(3-fluorophenyl)-5-phenylpyrazolo[1,5-a]pyrimidine

C24H24FN5 (401.2016)


   
   

(1S,5R)-3-[(3,5-dimethoxyphenyl)methyl]-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane

(1S,5R)-3-[(3,5-dimethoxyphenyl)methyl]-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane

C25H27N3O2 (401.2103)


   

3-[(3aS,4S,9bR)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

3-[(3aS,4S,9bR)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C25H27N3O2 (401.2103)


   

4-[(3aR,4R,9bR)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4R,9bR)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C25H27N3O2 (401.2103)


   

(2R,3S)-2-[(dimethylamino)methyl]-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-2-[(dimethylamino)methyl]-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H28FN3O3 (401.2115)


   

3-[(3aR,4S,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

3-[(3aR,4S,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C25H27N3O2 (401.2103)


   

3-[(3aR,4R,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

3-[(3aR,4R,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C25H27N3O2 (401.2103)


   
   
   
   
   
   

11-O-demethyl-17-O-deacetylvindolinium(1+)

11-O-demethyl-17-O-deacetylvindolinium(1+)

C22H29N2O5 (401.2076)


The conjugate acid of 11-O-demethyl-17-O-deacetylvindoline arising from protonation of the tertiary amino group; major species at pH 7.3.

   

(3s,6s)-3-benzyl-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-benzyl-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C25H27N3O2 (401.2103)


   

anti-isorhynchophylline n-oxide

anti-isorhynchophyllinen-oxide

C22H29N2O5 (401.2076)


{"Ingredient_id": "HBIN016374","Ingredient_name": "anti-isorhynchophylline n-oxide","Alias": "anti-isorhynchophyllinen-oxide","Ingredient_formula": "C22H29N2O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30613;1458","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-{[(2r,5s,6r)-6-hydroxy-5-(3-hydroxyquinoline-2-amido)oxan-2-yl]methyl}-3-methylbutanimidic acid

n-{[(2r,5s,6r)-6-hydroxy-5-(3-hydroxyquinoline-2-amido)oxan-2-yl]methyl}-3-methylbutanimidic acid

C21H27N3O5 (401.1951)


   

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

C21H27N3O5 (401.1951)


   

n-{[6-hydroxy-5-(3-hydroxyquinoline-2-amido)oxan-2-yl]methyl}-3-methylbutanimidic acid

n-{[6-hydroxy-5-(3-hydroxyquinoline-2-amido)oxan-2-yl]methyl}-3-methylbutanimidic acid

C21H27N3O5 (401.1951)